effect of Morus nigra L. on diabetic

Study of Morus nigra L. on HbA1c in diabetic patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201407163227N5

Enrollment

100

Registered

2016-08-13

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Diabetes mellitus

Interventions

Intervention 1: In case group, 3 cc of alcoholic extract of leaves of Morus nigra L. in a glass of water three times a day are given for 3 months. Intervention 2: In the control group for 3 months pla

Treatment - Other

Treatment - Drugs

In case group, 3 cc of alcoholic extract of leaves of Morus nigra L. in a glass of water three times a day are given for 3 months.

In the control group for 3 months placebo(Alcohol does mulberry leaf extract of Morus nigra L. ) are given

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: inclusion criteria included: Patients over 18 years; Type II diabetes for at least a year; Patients with blood levels of glycosylated hemoglobin of 7 to 9%; Recourse to the diabetes clinic in Khomeini city; consent to participate in research Exclusion criteria included: Pregnant women or those who are trying to conceive; lactating women; patients with physical and mental disorders; Patients who use herbal medicines, nearly as continuous doesn; Patients who have a special diet; Patients who use drugs addressing specific; diabetics insulin consume; patients younger than 18 years; having severe stress in the past 8 weeks; allergic to herbal medicines; Patients who have a need to change the amount of medicine; Patients who need to change their weight; Patients who need to change the quality of life.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1C. Timepoint: Before intervention and 3 Months after intervention. Method of measurement: blood test and biosystem kit.	—

Secondary

Measure	Time frame
Fasting blood sugar. Timepoint: Before intervention and 3 months after intervention. Method of measurement: blood test and Glucose (GOD) Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Momeni

Arak University of Medical Science

hamid52us@yahoo.com+98 864173638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026